Shares of lensmaker STAAR Surgical (STAA.O) rise 3.5% to $26.3 premarket.
Company's Q2 revenue of $93.5 million beats analysts' average expectation of $90.6 million, according to LSEG data.
It benefited from an increase in Chinese New Year-related procedures, and more significantly, a shift in military recruitment vision screenings, the company says.
STAAR Surgical sells implantable lenses for the eye and systems used to deliver the lenses into the eye.
STAA•
